Taming the dynamics in a pharmaceutical by cocrystallization: investigating the impact of the coformer by solid-state NMR

Pharmaceuticals in their crystalline state may display a range of dynamics that can affect their physicochemical properties and chemical stability. With pharmaceutical cocrystals continuing to gain attention, there is an opportunity to investigate how the dynamics are changing in these new solid forms. Here, we investigate the dynamics in efavirenz, an anti-HIV drug, and a series of its cocrystals using a combination of DFT calculations and solid-state magic-angle spinning (MAS) NMR spectroscopy. We show that the crystalline form of efavirenz has a highly dynamic cyclopropyl group, and displays additional rocking motion. In contrast, the dynamics in the efavirenz cocrystals appear to be tamed, with the cyclopropyl group in the (efavirenz)(l-proline) cocrystal being the most constrained, and these constraints originating from a more favourable crystal packing in the cocrystals.

Automated summary

The study revealed that the dynamics in the crystalline form of efavirenz are significant, whereas the dynamics in its cocrystals with l-proline are constrained, with the cyclopropyl group being the most constrained due to a more favorable crystal packing in the cocrystals.